Redefining Tumor Vascular Permeability through Deep Learning-Guided Microneedle Delivery
Low-permeability (LP) tumor vasculature constitutes a major barrier to efficient nanomedicine delivery, making quantitative assessment and mechanistic understanding of vascular permeability essential for the rational design of delivery strategies. Here, we introduce a deep learning-guided microneedle (MN) delivery platform that enables localized and spatiotemporally precise modulation of tumor vasculature to enhance nanoparticle extravasation. By integrating the MN system with an upgraded single-vessel analysis framework (nano-ISML 1.1), we quantitatively mapped vascular remodeling and nanoparticle transport across diverse tumor types and particle sizes. Localized histamine delivery via MNs selectively expanded endothelial junctions through VE-cadherin-mediated regulation, significantly increasing the frequency and length of interendothelial gaps, and thereby reprogramming LP tumors toward a high-permeability phenotype. This controlled vascular remodeling established a pronounced size-dependent permeability window, defined by locally induced gap dimensions that varied across tumor types, permitting efficient penetration of nanoparticles ≤200 nm while largely excluding particles >500 nm. By uniting nanotechnology, vascular biology, and artificial intelligence, this interdisciplinary framework provides a mechanistic and predictive paradigm for overcoming vascular barriers and advancing the rational design of tumor-targeted nanomedicines.
Authors
- Yingqi Miao
- Jin Wu (ORCID: https://orcid.org/0000-0001-6778-547X)
- Jingwei Tian (ORCID: https://orcid.org/0009-0005-7930-0018)
- Che Zhou
- Xinglu Huang
- Mingsheng Zhu
- Jie Zhuang
- Jianxin Liu
- Yuanke Li
- Xiangyang Wang
- Qiqi Liu
Institutions
- Nankai University (CN)
- Kementerian Pendidikan Malaysia (MY)
- Indiana University School of Medicine
Publication Details
- Journal
- ACS Nano
- Published
- 2026-02-09
- DOI
- https://doi.org/10.1021/acsnano.5c16558
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00